Colorectal cancer is the third most common cancer in Korea and the third leading cause of death from cancer. Treatment outcomes for colon cancer are steadily improving due to national health screening programs with advances in diagnostic methods, surgical techniques, and therapeutic agents.. The Korea Colon Cancer Multidisciplinary (KCCM) Committee intends to provide professionals who treat colon cancer with the most up-to-date, evidence-based practice guidelines to improve outcomes and help them make decisions that reflect their patients’ values and preferences. These guidelines have been established by consensus reached by the KCCM Guideline Committee based on a systematic literature review and evidence synthesis and by considering the national health insurance system in real clinical practice settings. Each recommendation is presented with a recommendation strength and level of evidence based on the consensus of the committee.

Lee SY, et al. Ann Surg Treat Res. 2022 Sep;103(3):176-182. https://doi.org/10.4174/astr.2022.103.3.176

Park HM, et al. Ann Surg Treat Res. 2022 Aug;103(2):87-95. https://doi.org/10.4174/astr.2022.103.2.87

Soo Young Lee, Hyeung-min Park, Chang Hyun Kim, Hyeong Rok Kim. Ann Clin Nutr Metab 2023;15:46-50. https://doi.org/10.15747/ACNM.2023.15.2.46

Park HM, et al. Ann Surg Treat Res. 2025 Jan;108(1):49-56. https://doi.org/10.4174/astr.2025.108.1.49